A Pilot Study Comparing the Analgesic Efficacy of IV Ibuprofen and IV Ketorolac
Unknown statusPhase 4NCT01514175
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The primary objective of this study is to compare the efficacy of a single dose of intravenous ibuprofen compared to a single dose of ketorolac for the treatment of postoperative pain as measured by patient pain intensity (Visual Analog Scale, VAS).
Study details
- Official title
- A Pilot Study Comparing the Analgesic Efficacy of IV Ibuprofen and IV Ketorolac
- Conditions
- Interventions
- Drug: IV Ibuprofen
- Drug: IV Ketorolac
- Sponsor
- Culpeper Surgery Center
- Collaborators
- Cumberland Pharmaceuticals
- Start date
- 2012-01
- Primary completion
- 2012-12
- Sex
- Female
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with a preoperative diagnosis which is inclusive of chronic pelvic pain scheduled for Laparoscopic Surgery Exclusion Criteria: * Inadequate IV access. * History of allergy or hypersensitivity to any component of IVIb,ketorolac, aspirin (or aspirin related products), NSAIDs, or COX-2 inhibitors. * Less than 18 years of age or Greater than 65 years of age. * Use of analgesics, including NSAIDs, less than 12 hours prior to surgery. * Patients with active, clinically significant anemia. * History or evidence of asthma or heart failure. * Pregnant. * Inability to understand the requirements of the study, be willing to provide written informed consent (as evidenced by signature on an informed consent document approved by an Institutional Review Board \[IRB\]), and agree to abide by the study restrictions and to return for the required assessments. * Refusal to provide written authorization for use and disclosure of protected health information. * Patients with a history of Chronic Pain Conditions or Syndromes excluding patients with Chronic Pelvic Pain. * Patients with known OSA
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01514175